Close this search box.
Lightsense Technology on SeedInvest
Health & WellnessTech

Lightsense Technology

Patented multispectral technology using light to detect illicit drugs and disease 
Investment type:
(Preferred Equity (Seed))
Target raise:
 - $2,000,000
Minimum investment:​
End date:
Jan 15, 2022

  • IP includes one company-assigned patent and five exclusive license agreements for relevant patents so far; and five patent applications in process
  • In limited company-conducted studies, the EPS technology has been successfully demonstrated to show it can be utilized to identify the viruses in human saliva in less than one minute, which is much faster than the PCR times of many minutes to hours
  • DrugDetect, the company’s first product, is a handheld spectrometer that has been trialed with law enforcement in Arizona, Ohio, and Utah, with departments from other states in discussions now
  • Strategic memorandum of understanding with a leading technology and engineering company that has deep AI expertise in order to bring the multi-spectral solution to the chemical & biological threat detection market
  • Recipient of a Phase I Small Business Innovation Research (SBIR) grant award from the Defense Logistics Agency of the U.S. Department of Defense to further develop detection technology